PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
PT Kalbe Farma Debt to Equity Ratio : 0.034 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.034 |
| March 31, 2026 | 0.0126 |
| December 31, 2025 | 0.0128 |
| September 30, 2025 | 0.0227 |
| June 30, 2025 | 0.0349 |
| March 31, 2025 | 0.0227 |
| December 31, 2024 | 0.0246 |
| September 30, 2024 | 0.0335 |
| June 30, 2024 | 0.0467 |
| March 31, 2024 | 0.0313 |
| December 31, 2023 | 0.029 |
| September 30, 2023 | 0.0525 |
| June 30, 2023 | 0.0918 |
| March 31, 2023 | 0.0419 |
| December 31, 2022 | 0.0573 |
| September 30, 2022 | 0.0557 |
| June 30, 2022 | 0.0326 |
| March 31, 2022 | 0.0375 |
| December 31, 2021 | 0.032 |
| September 30, 2021 | 0.0387 |
| June 30, 2021 | 0.0452 |
| March 31, 2021 | 0.0441 |
| December 31, 2020 | 0.0665 |
| September 30, 2020 | 0.085 |
| June 30, 2020 | 0.1036 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0745 |
| December 31, 2019 | 0.0514 |
| September 30, 2019 | 0.0478 |
| June 30, 2019 | 0.0508 |
| March 31, 2019 | 0.0332 |
| December 31, 2018 | 0.0244 |
| September 30, 2018 | 0.0187 |
| June 30, 2018 | 0.0262 |
| March 31, 2018 | 0.0243 |
| December 31, 2017 | 0.0248 |
| September 30, 2017 | 0.0386 |
| June 30, 2017 | 0.0274 |
| March 31, 2017 | 0.0254 |
| December 31, 2016 | 0.0238 |
| September 30, 2016 | 0.0269 |
| June 30, 2016 | 0.034 |
| March 31, 2016 | 0.0383 |
| December 31, 2015 | 0.0381 |
| September 30, 2015 | 0.041 |
| June 30, 2015 | 0.045 |
| March 31, 2015 | 0.0248 |
| December 31, 2014 | 0.0316 |
| September 30, 2014 | 0.06 |
| June 30, 2014 | 0.0722 |
| March 31, 2014 | 0.0655 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AstraZeneca PLC | 0.7166 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Avadel Pharmaceuticals Plc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.850B |
| Total Liabilities (Quarterly) | 409.06M |
| Shareholders Equity (Quarterly) | 1.361B |
| Current Ratio | 3.153 |
| Net Debt Paydown Yield | -0.15% |